Metraipolis › archive › dc_3140dd5ada15

Do Serum Brain Biomarkers Differentiate the Hemorrhagic Head Injury Lesion Phenotypes? An Interim Analysis of an On-Going Randomized Clinical Trial — Europe PMC PMID:41898376

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41898376
DOI
10.3390/biomedicines14030732
License (as archived)
solo-consultazione
Archived
2026-11-04T01:41:36.564Z
SHA-256 of the archived text
242667b7ec2f63340a3045d5d16daada3ea6398927f52384d4999e2aef60c737
Stable URL of this page
https://metraipolis.com/documento/dc_3140dd5ada15

How to cite

Do Serum Brain Biomarkers Differentiate the Hemorrhagic Head Injury Lesion Phenotypes? An Interim Analysis of an On-Going Randomized Clinical Trial — Europe PMC PMID:41898376 — Europe PMC (en), https://europepmc.org/article/MED/41898376 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3140dd5ada15 (Metraipolis archive dc_3140dd5ada15, sha256 242667b7ec2f63340a3045d5d16daada3ea6398927f52384d4999e2aef60c737)
BibTeX
@misc{dc3140dd5ada15,
  title = {Do Serum Brain Biomarkers Differentiate the Hemorrhagic Head Injury Lesion Phenotypes? An Interim Analysis of an On-Going Randomized Clinical Trial — Europe PMC PMID:41898376},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41898376},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3140dd5ada15; sha256 242667b7ec2f63340a3045d5d16daada3ea6398927f52384d4999e2aef60c737},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41898376. Agents can read the archived copy with the MCP tool read_document.